Conception, Synthesis, and Characterization of a Rofecoxib-Combretastatin Hybrid Drug With Potent Cyclooxygenase-2 (COX-2) Inhibiting and Microtubule Disrupting Activities in Colon Cancer Cell Culture and Xenograft Models
Oncotarget - United States
doi 10.18632/oncotarget.25450
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 12, 2018
Authors
Publisher
Impact Journals, LLC